BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35168037)

  • 21. Miniature tissue-equivalent proportional counters for BNCT and BNCEFNT dosimetry.
    Burmeister J; Kota C; Maughan RL; Waker AJ
    Med Phys; 2001 Sep; 28(9):1911-25. PubMed ID: 11585222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microdosimetry study of THOR BNCT beam using tissue equivalent proportional counter.
    Hsu FY; Hsiao HW; Tung CJ; Liu HM; Chou FI
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S175-8. PubMed ID: 19447042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimentally determined relative biological effectiveness of cyclotron-based epithermal neutrons designed for clinical BNCT: in vitro study.
    Hu N; Suzuki M; Masunaga SI; Kashino G; Kinashi Y; Chen YW; Liu Y; Uehara K; Mitsumoto T; Tanaka H; Ono K
    J Radiat Res; 2023 Sep; 64(5):811-815. PubMed ID: 37607589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current Status of Accelerator-Based Boron Neutron Capture Therapy (BNCT)].
    Tanaka H
    Igaku Butsuri; 2021; 41(3):117-121. PubMed ID: 34744121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric performance evaluation regarding proton beam incident angles of a lithium-based AB-BNCT design.
    Lee PY; Liu YH; Jiang SH
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):403-9. PubMed ID: 24493784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microdosimetry of neutron field for boron neutron capture therapy at Kyoto university reactor.
    Endo S; Onizuka Y; Ishikawa M; Takada M; Sakurai Y; Kobayashi T; Tanaka K; Hoshi M; Shizuma K
    Radiat Prot Dosimetry; 2004; 110(1-4):641-4. PubMed ID: 15353723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BNCT microdosimetry at the tapiro reactor thermal column.
    De Nardo L; Seravalli E; Rosi G; Esposito J; Colautti P; Conte V; Tornielli G
    Radiat Prot Dosimetry; 2004; 110(1-4):579-86. PubMed ID: 15353712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational assessment of deep-seated tumor treatment capability of the 9Be(d,n)10B reaction for accelerator-based boron neutron capture therapy (AB-BNCT).
    Capoulat ME; Minsky DM; Kreiner AJ
    Phys Med; 2014 Mar; 30(2):133-46. PubMed ID: 23880544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimized beam shaping assembly for a 2.1-MeV proton-accelerator-based neutron source for boron neutron capture therapy.
    Torres-Sánchez P; Porras I; Ramos-Chernenko N; Arias de Saavedra F; Praena J
    Sci Rep; 2021 Apr; 11(1):7576. PubMed ID: 33828211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerator driven neutron source design via beryllium target and
    Khorshidi A
    J Cancer Res Ther; 2017; 13(3):456-465. PubMed ID: 28862209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dosimetry system for boron neutron capture therapy based on the dual counter microdosimetric technique.
    Kota C; Maughan RL
    Bull Cancer Radiother; 1996; 83 Suppl():173s-5s. PubMed ID: 8949773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A design study for an accelerator-based epithermal neutron beam for BNCT.
    Allen DA; Beynon TD
    Phys Med Biol; 1995 May; 40(5):807-21. PubMed ID: 7652009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the characteristics of the neutron beam of a linac-based neutron source for boron neutron capture therapy.
    Kumada H; Takada K; Tanaka S; Matsumoto Y; Naito F; Kurihara T; Sugimura T; Sato M; Matsumura A; Sakurai H; Sakae T
    Appl Radiat Isot; 2020 Nov; 165():109246. PubMed ID: 32692654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal moderator materials at various proton energies considering photon dose rate after irradiation for an accelerator-driven ⁹Be(p, n) boron neutron capture therapy neutron source.
    Hashimoto Y; Hiraga F; Kiyanagi Y
    Appl Radiat Isot; 2015 Dec; 106():88-91. PubMed ID: 26272165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of TEPC microdosimetry to boron neutron capture therapy.
    Burmeister J; Kota C; Maughan RL; Waker AJ; Riley K; Wielopolski L
    Radiat Prot Dosimetry; 2002; 99(1-4):351-2. PubMed ID: 12194321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
    Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
    Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience.
    Porra L; Wendland L; Seppälä T; Koivunoro H; Revitzer H; Tervonen J; Kankaanranta L; Anttonen A; Tenhunen M; Joensuu H
    Cancer Biother Radiopharm; 2023 Apr; 38(3):184-191. PubMed ID: 36269660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of boron neutron capture therapy used neutron source with protons bombarding a thick 9Be target.
    Yue G; Chen J; Song R
    Med Phys; 1997 Jun; 24(6):851-5. PubMed ID: 9198018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of Beam Shaping Assemblies for Accelerator-Based BNCT With Multi-Terminals.
    Li G; Jiang W; Zhang L; Chen W; Li Q
    Front Public Health; 2021; 9():642561. PubMed ID: 33777888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell survival measurements in an argon, aluminium and sulphur filtered neutron beam: a comparison with 24 keV neutrons and relevance to boron neutron capture therapy.
    Mill AJ; Morgan GR; Newman SM
    Br J Radiol; 1994 Oct; 67(802):1008-16. PubMed ID: 8000825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.